메뉴 건너뛰기




Volumn 25, Issue 1, 2011, Pages 50-56

Attention deficit hyperactivity disorder: Part III

Author keywords

Attention deficit hyperactivity disorder; Behavioral interventions; Educational interventions; Mental health interventions; Non stimulants; Stimulants

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PROPYLAMINE;

EID: 78649949088     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2010.10.001     Document Type: Article
Times cited : (4)

References (29)
  • 1
    • 0034011569 scopus 로고    scopus 로고
    • Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder
    • American Academy of Pediatrics
    • Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000, 105(5):1158-1170. American Academy of Pediatrics.
    • (2000) Pediatrics , vol.105 , Issue.5 , pp. 1158-1170
  • 2
    • 0004235298 scopus 로고    scopus 로고
    • American Psychiatric Association, Author, Washington, DC
    • Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Author, Washington, DC. 4th ed., text revision.
    • (2000) Diagnostic and statistical manual of mental disorders
  • 4
    • 0036893022 scopus 로고    scopus 로고
    • Practical considerations in stimulant drug selection for the attention deficit/hyperactivity disorder patient
    • Biederman J. Practical considerations in stimulant drug selection for the attention deficit/hyperactivity disorder patient. Today's Therapeutic Trends 2002, 20(4):311-328.
    • (2002) Today's Therapeutic Trends , vol.20 , Issue.4 , pp. 311-328
    • Biederman, J.1
  • 5
    • 22144455050 scopus 로고    scopus 로고
    • Attention-deficit hyperactivity disorder
    • Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366:237-248.
    • (2005) Lancet , vol.366 , pp. 237-248
    • Biederman, J.1    Faraone, S.V.2
  • 6
  • 7
    • 55949125057 scopus 로고    scopus 로고
    • Educational rights of children and adolescents with attention deficit/hyperactivity disorder
    • Cohen M. Educational rights of children and adolescents with attention deficit/hyperactivity disorder. Adolescent Medicine State of the Art Review 2008, 19(2):327-338.
    • (2008) Adolescent Medicine State of the Art Review , vol.19 , Issue.2 , pp. 327-338
    • Cohen, M.1
  • 8
    • 77954750380 scopus 로고    scopus 로고
    • Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents
    • Connor D.F., Rubin J. Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents. Drugs Today 2010, 46(5):299-314.
    • (2010) Drugs Today , vol.46 , Issue.5 , pp. 299-314
    • Connor, D.F.1    Rubin, J.2
  • 10
    • 65949112261 scopus 로고    scopus 로고
    • Atomoxetine: A review of its use in attention-deficit hyperactivity disorder in children and adolescents
    • Garnock-Jones K.P., Keating G.M. Atomoxetine: A review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatric Drugs 2009, 11(3):203-226.
    • (2009) Paediatric Drugs , vol.11 , Issue.3 , pp. 203-226
    • Garnock-Jones, K.P.1    Keating, G.M.2
  • 12
    • 0043092213 scopus 로고    scopus 로고
    • A transactional model of oppositional behavior: Underpinnings of the collaborative problem solving approach
    • Greene R.W., Ablon J.S., Goring J.C. A transactional model of oppositional behavior: Underpinnings of the collaborative problem solving approach. Journal of Psychosomatic Research 2003, 55(1):67-75.
    • (2003) Journal of Psychosomatic Research , vol.55 , Issue.1 , pp. 67-75
    • Greene, R.W.1    Ablon, J.S.2    Goring, J.C.3
  • 13
    • 0033035728 scopus 로고    scopus 로고
    • Use of the Pediatric Symptom Checklist (PSC) to screen for psychosocial problems in pediatric primary care: A national feasibility study
    • Jellinek M., Murphy J., Little M., Pagano M., Comer D., Kelleher K. Use of the Pediatric Symptom Checklist (PSC) to screen for psychosocial problems in pediatric primary care: A national feasibility study. Archives of Pediatric and Adolescent Medicine 1999, 153(3):254-260.
    • (1999) Archives of Pediatric and Adolescent Medicine , vol.153 , Issue.3 , pp. 254-260
    • Jellinek, M.1    Murphy, J.2    Little, M.3    Pagano, M.4    Comer, D.5    Kelleher, K.6
  • 17
    • 2942697466 scopus 로고    scopus 로고
    • Simon and Schuster, New York, NY
    • Levine M. A mind at a time 2002, Simon and Schuster, New York, NY.
    • (2002) A mind at a time
    • Levine, M.1
  • 18
    • 0032038656 scopus 로고    scopus 로고
    • The Screen for Child Anxiety Related Emotional Disorders (SCARED): Relationship with anxiety and depression in normal children
    • Muris P., Merckelbach H., van Brakel A., Mayer B., van Dongen L. The Screen for Child Anxiety Related Emotional Disorders (SCARED): Relationship with anxiety and depression in normal children. Personality and Individual Differences 1998, 24:451-456.
    • (1998) Personality and Individual Differences , vol.24 , pp. 451-456
    • Muris, P.1    Merckelbach, H.2    van Brakel, A.3    Mayer, B.4    van Dongen, L.5
  • 19
    • 49849084131 scopus 로고    scopus 로고
    • Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder
    • The Black Box Working Group and Section on Cardiology and Cardiac Surgery
    • Perrin J., Freidman R., Knilans T. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 2008, 122:451-453. The Black Box Working Group and Section on Cardiology and Cardiac Surgery.
    • (2008) Pediatrics , vol.122 , pp. 451-453
    • Perrin, J.1    Freidman, R.2    Knilans, T.3
  • 20
    • 33847611933 scopus 로고    scopus 로고
    • Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action
    • Pliszka S.R. Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action. Neuropsychology Review 2007, 17(1):61-72.
    • (2007) Neuropsychology Review , vol.17 , Issue.1 , pp. 61-72
    • Pliszka, S.R.1
  • 23
    • 77951097681 scopus 로고    scopus 로고
    • Attention deficit hyperactivity disorder: Part I
    • Ryan-Krause P. Attention deficit hyperactivity disorder: Part I. Journal of Pediatric Health Care 2010, 24:194-198.
    • (2010) Journal of Pediatric Health Care , vol.24 , pp. 194-198
    • Ryan-Krause, P.1
  • 24
    • 77956170174 scopus 로고    scopus 로고
    • Attention deficit hyperactivity disorder: Part II
    • Ryan-Krause P. Attention deficit hyperactivity disorder: Part II. Journal of Pediatric Health Care 2010, 24:338-342.
    • (2010) Journal of Pediatric Health Care , vol.24 , pp. 338-342
    • Ryan-Krause, P.1
  • 25
    • 67650904184 scopus 로고    scopus 로고
    • Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention deficit/hyperactivity disorder
    • Sallee F., Lyne A., Stat C., Wigel T. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention deficit/hyperactivity disorder. Journal of Child and Adolescent Pharmacology 2009, 19(3):215-226.
    • (2009) Journal of Child and Adolescent Pharmacology , vol.19 , Issue.3 , pp. 215-226
    • Sallee, F.1    Lyne, A.2    Stat, C.3    Wigel, T.4
  • 26
    • 77956321130 scopus 로고    scopus 로고
    • Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder
    • Stiefel G., Besag F.M. Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Safety 2010, 33(10):821-842.
    • (2010) Drug Safety , vol.33 , Issue.10 , pp. 821-842
    • Stiefel, G.1    Besag, F.M.2
  • 27
    • 77951698882 scopus 로고    scopus 로고
    • Attention-deficit/hyperactivity disorder and sleep disorders in children
    • Tsai M.-H., Huang Y.-S. Attention-deficit/hyperactivity disorder and sleep disorders in children. Medical Clinics of North America 2010, 94:615-632.
    • (2010) Medical Clinics of North America , vol.94 , pp. 615-632
    • Tsai, M.-H.1    Huang, Y.-S.2
  • 29
    • 43249096555 scopus 로고    scopus 로고
    • Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing
    • Vetter V.L., Elia J., Erickson C., Berger S., Blum N., Uzark K., Webb C. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 2008, 117:2407-2423.
    • (2008) Circulation , vol.117 , pp. 2407-2423
    • Vetter, V.L.1    Elia, J.2    Erickson, C.3    Berger, S.4    Blum, N.5    Uzark, K.6    Webb, C.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.